General Information of the Compound
Compound ID |
CP0125179
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-(4-methoxyphenyl)-5H-indeno[1,2-c]pyridazin-5-one
Show/Hide
|
||||||||||||||||||
Synonyms |
147508-58-5
3-(4-Methoxyphenyl)-5H-indeno[1,2-c]pyridazin-5-one
3-(4-methoxyphenyl)indeno[1,2-c]pyridazin-5-one
5H-indeno[1,2-c]pyridazin-5-one, 3-(4-methoxyphenyl)-
AC1L8E6Y
AC1Q6KMT
AKOS005075095
BDBM21618
CBDivE_007579
CHEMBL125044
CTK7A3357
GNF-PF-2812
HMS2631I03
Indeno[1,2-c]pyridazin-5-one, 6
KS-00001QSJ
MCULE-6151549558
MLS000691948
MMV666026
MolPort-002-851-046
NCI60_021917
NSC-663884
NSC663884
Oprea1_523550
SMR000333991
STK336082
ZINC196663
cid_379338
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C18H12N2O2
|
||||||||||||||||||
Molecular Weight |
288.306
|
||||||||||||||||||
Canonical SMILES |
COc1ccc(cc1)-c1cc2C(=O)c3ccccc3-c2nn1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C18H12N2O2/c1-22-12-8-6-11(7-9-12)16-10-15-17(20-19-16)13-4-2-3-5-14(13)18(15)21/h2-10H,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
HXQRIHGYIOARQJ-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Protein ID: PT06033, Microphthalmia-associated transcription factor
Clinical Information about the Compound